AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.
24/7 Wall St. on MSN6d
AbbVie Just Paid Investors: Here's How Much They ReceivedAbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 ...
DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation. The company holds strong positions in rapidly growing markets ...
Non-profit healthcare provider HCA Inc printed the biggest trade of the week as it raised $5.25bn in a six-part offering to repay its borrowing facility. Wells Fargo, Barclays, Bank of America, Citi, ...
Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...
Danaher, Recursion Pharmaceuticals, Moderna, Thermo Fisher Scientific, AbbVie, Vertex Pharmaceuticals, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Booking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback